Heghine Khachatryan: Balancing Thrombosis and Bleeding Risks in Acute Leukemia
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Seminars in Thrombosis and Hemostasis‘ post on LinkedIn about a recent article by Shay Perek et al., published in Seminars in Thrombosis and Hemostasis, adding:
“Balancing Thrombosis and Bleeding Risks in Acute Leukemia
Managing catheter-related thrombosis in patients with acute leukemia remains a significant clinical challenge, particularly in the presence of severe thrombocytopenia.
A recent study by Perek et al., published in Seminars in Thrombosis and Hemostasis, provides valuable real-world evidence on a platelet-count-guided low-molecular-weight heparin (LMWH) strategy.
The findings highlight the potential role of individualized anticoagulation in this particularly vulnerable patient population.
Importantly, the absence of statistically significant differences in clinical outcomes should not be interpreted as evidence of therapeutic equivalence, given the observational nature of the study.
The key clinical message is clear: anticoagulation decisions should integrate platelet counts, thrombotic risk, bleeding risk, and the individual clinical context.
Further prospective studies are essential to establish optimal management strategies.
Congratulations to the authors for addressing this important clinical challenge.”
Seminars in Thrombosis and Hemostasis shared a post on LinkedIn:
“Managing catheter-related thrombosis in patients with acute leukemia presents a unique clinical challenge, especially when thrombocytopenia limits anticoagulation options.
A new study in Seminars in Thrombosis and Hemostasis evaluates a platelet-count-guided low molecular weight heparin (LMWH) strategy for the management of catheter-related thrombosis in a large cohort of patients with newly diagnosed acute leukemia, providing important real-world evidence for balancing thrombosis and bleeding risks.”
Title: Platelet-Count-Guided Low Molecular Weight Heparin Management of Catheter-Related Thrombosis in a Large Cohort of Patients with Newly Diagnosed Acute Leukemia
Authors: Shay Perek, Niv Izhaki, Ron Hoffman, Benjamin Brenner, Netanel A. Horowitz
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery